Ozempic Weight Loss Service in San Diego: What Physician-Supervised Care Looks Like Ozempic (semaglutide) was originally FDA-approved in 2017 for the management of Type 2 diabetes. Clinical evidence quickly revealed something significant alongside its primary indication: patients using it were also losing substantial body weight. Visit: https://ihowtoarticle.com/ozempic-weight-loss-service-in-san-diego-what-physician-supervised-care-looks-like/